LYC Healthcare Berhad (KLSE:LYC)
Malaysia · Delayed Price · Currency is MYR 0.0050
0.00 (0.00%)
At close: Aug 7, 2026
LYC Healthcare Berhad Financials Overview
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 134.19 | 134.19 | 155.52 | 128.99 | 92.28 | 64.6 |
Revenue Growth | -13.71% | -13.71% | 20.57% | 39.78% | 42.86% | 144.56% |
Gross Profit Gross Profit Growth | 72.7 | 72.7 | 68.97 | 68.27 | 41.58 | 32.19 |
Operating Income Operating Income Growth | 0.8 | 0.8 | 4.24 | -1.67 | 1.57 | 7.64 |
Net Income Net Income Growth | -23.27 | -23.27 | -17.07 | -20.78 | -19.19 | -9.23 |
Earnings Per Share EPS Growth | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Others Others Growth | 2.79 | 2.79 | 7.56 | 5.04 | 2.25 | 0 |
Healthcare Services Healthcare Services Growth | 134.39 | 134.39 | 153.14 | 129.3 | 89.4 | 60.98 |
Computing and Electronic Services Computing and Electronic Services Growth | 0.39 | 0.39 | 2.84 | 3.05 | 3.81 | 4.61 |
Elimination Elimination Growth | -3.38 | -3.38 | -8.02 | -8.41 | -3.18 | -1 |
Total Total Growth | 134.19 | 134.19 | 155.52 | 128.99 | 92.28 | 64.6 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 17.47 | 17.47 | 8.96 | 16.91 | 40.75 | 22.12 |
Total Debt Total Debt Growth | 119.16 | 119.16 | 138.19 | 138.15 | 115.22 | 124.04 |
Net Cash (Debt) Net Cash Growth | -101.69 | -101.69 | -129.23 | -121.23 | -74.47 | -101.93 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.14 | -0.14 | -0.18 | -0.17 | -0.14 | -0.23 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 24.26 | 24.26 | 28.7 | 10.74 | 4.99 | 0.34 |
Capital Expenditures CapEx Growth | - | - | -5.65 | -5.7 | -2.53 | -2.88 |
Free Cash Flow Free Cash Flow Growth | 24.26 | 24.26 | 23.06 | 5.03 | 2.46 | -2.54 |
Free Cash Flow Growth | 5.22% | 5.22% | 358.08% | 104.68% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 54.17% | 54.17% | 44.35% | 52.92% | 45.06% | 49.83% |
Operating Margin | 0.59% | 0.59% | 2.73% | -1.29% | 1.70% | 11.83% |
Pretax Margin | -7.34% | -7.34% | -5.20% | -9.96% | -12.86% | -1.89% |
Profit Margin | -17.34% | -17.34% | -10.97% | -16.11% | -20.79% | -14.28% |
FCF Margin | 18.08% | 18.08% | 14.82% | 3.90% | 2.67% | -3.93% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Forward PE | - | 16.50 | 16.50 | 16.50 | 16.50 | 16.50 |
P/FCF Ratio | 0.15 | 0.46 | 2.02 | 26.28 | 68.72 | - |
PS Ratio | 0.03 | 0.08 | 0.30 | 1.02 | 1.83 | 1.76 |